ArticleIBRO neuroscience reports2026
Piezoelectric cold atmospheric plasma modulates neurogenic cell proliferation and differentiation via cross-signaling.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cold atmospheric plasma regulates cell fate by modulating cellular oxidative stress levels, making it a promising new therapy in the field of cell bioengineering. While the regulatory effects and potential molecular mechanisms of the novel piezoelectric cold atmospheric plasma (Piezo-CAP, PiezoBrush PZ3 handheld device, Relyon Plasma, Germany) on the fate of neurogenic cells remain unclear. We utilized C17.2 neural stem cells, rat astrocytes, and SH-SY5Y neuroblastoma cells to evaluate the impact of Piezo-CAP on cell proliferation, apoptosis, and differentiation through CCK-8 assay, Calcein AM/PI double staining, immunofluorescence, and western blot techniques. The signal network of Piezo-CAP governing neurogenic cell proliferation and differentiation was thoroughly examined by the merging of RNA sequencing and bioinformatics analysis. The results demonstrated that Piezo-CAP has a dual regulatory influence on neurogenic cell fate, dependent on specific parameters and cell types. Significantly, Piezo-CAP enables the bidirectional differentiation of C17.2 neural stem cells into neurons and glial cells. The described effects are mechanistically associated with the buildup of intracellular reactive oxygen and nitrogen species (RONS) and may be enhanced by the activation of the PI3K/AKT signaling pathway. Transcriptome research further confirms that Piezo-CAP can influence signaling pathways related to the maintenance of pluripotency and differentiation, including JAK-STAT, Wnt, and Hippo signaling. In conclusion, Piezo-CAP, as an effective physical stimulation method, may accurately influence the destiny of neurogenic cells through essential signaling pathways facilitated by RONS, including PI3K/AKT. This research provides actual evidence and innovative strategies for the application of Piezo-CAP in neural therapy and neural tissue engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.